ClinicalTrials.gg
RecruitingNCT07429344EASY AlgorithmUpdated Apr 8, 2026

EASY Algorithm Trial (Elbow Trauma Assessment Using Sonography in Children and Youth) Diagnostic Accuracy and Safety of Point-of-care Ultrasound as a Screening Tool for Suspected Elbow Fractures in Children Aged 5 to 15 Years: a Multicenter Prospective Cohort Study

An observational study in Elbow Fractures, Distal Humerus Fracture and Pediatric Trauma, sponsored by Timo Munz. Recruiting at 13 sites in Germany. Open to participants aged 5 Years to 15 Years. Per ClinicalTrials.gov, last updated 2026-04-08.

Sponsored by Timo Munz · Observational

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
543
Ages
5 Years to 15 Years
Sex
All
01

Study summary

The goal of this observational study is to learn about the safety and accuracy of ultrasound as a screening tool to detect broken bones (fractures) in the elbow area in children and youth aged 5 to 15 years. The main question it aims to answer is:

- Can ultrasound reliably show that there is a fracture in the elbow area after an accident?

Participants will:

  • Have an ultrasound of their elbow to look for fluid in the joint.
  • Have standard X-rays of their elbow to check if there is a fracture.
  • Have their medical records checked and answer a phone call 6 weeks later to see how their elbow has healed (only if no fracture was found during the first visit).
02

Conditions studied

  • Elbow Fractures
  • Distal Humerus Fracture
  • Pediatric Trauma
  • Radius Fracture
  • Olecranon Fracture
  • Supracondylar Humerus Fracture

Keywords

  • EASY Algorithm Trial
  • pediatric trauma
  • Diagnostic accuracy
  • point-of-care ultrasound
  • elbow fractures
  • children
  • Elbow Trauma Assessment using Sonography in Children and Youth
  • German Section for Pediatric Traumatology (SKT)
  • screening tool
  • supracondylar humerus fracture
03

In context

Elbow Fractures

48 studies on the registry are indexed under Elbow Fractures; 14 are open to participants now.

This study's planned enrollment of 543 is above the median of 58 across 16 observational studies indexed under Elbow Fractures.

Browse Elbow Fractures studies →

Lead sponsor

This is the only study on the registry with Timo Munz as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All children and adolescents who present to the emergency departments of the participating hospitals with elbow pain following an accident will be screened for inclusion in the study during the study period until the statistically determined required number of cases has been reached.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • children and adolescents aged 5-15 years with anamnestic and clinically justified need for the exclusion of a fracture after elbow trauma

Exclusion criteria

Exclusion Criteria:

  • elbow trauma as part of a polytrauma,
  • parents' insufficient German language skills (spoken or written),
  • trauma more than 72 hours ago,
  • presentation at the emergency room with current, post-traumatic external X-ray images of the affected elbow joint from another clinic or practice,
  • open fracture of the affected elbow joint,
  • skin avulsion of the affected elbow joint,
  • visible deformity of the affected elbow joint,
  • and pathological status of peripheral circulation, motor function, and/or sensitivity.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
543 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Sensitivity of sonographic joint effusion

    Sensitivity of sonographic joint effusion examination following a standardized procedure and uniform training of the physicians performing the examination in the detection of radiologically confirmed elbow fractures, as assessed by blinded experts.

    Time frame: Day 1 (On the day of enrollment in the study in the emergency department)

Secondary outcomes

  1. Time required for ultrasound examination

    The total time for performing and evaluating the ultrasound examination is measured.

    Time frame: Day 1 (On the day of enrollment in the study in the emergency department)

  2. The additional time patients spend in the emergency room due to X-ray examinations

    The time that patients and their relatives spend additionally in the emergency room due to X-ray imaging is measured. The time at which the family leaves the treatment room after the ultrasound is noted. Then the time at which the family re-enters the treatment room after the X-ray is performed is noted. The difference is the additional time patients spend in the emergency room due to X-ray imaging.

    Time frame: Day 1 (On the day of enrollment in the study in the emergency department)

  3. Radiation dose from X-ray imaging (dose area product)

    The radiation dose of the initial radiological imaging (dose area product) is recorded.

    Time frame: Day 1 (On the day of enrollment in the study in the emergency department)

  4. The initial assessment of the X-ray images by the attending physician in the emergency department

    The exact fracture type determined by the attending physician in the emergency department.

    Time frame: Day 1 (On the day of enrollment in the study in the emergency department)

  5. Treatment of the injury

    In the case of a fracture diagnosed by X-ray, the initial treatment is recorded. If the initial X-ray image shows no fracture, the initial symptomatic treatment is recorded. If there is initially no radiographic evidence of a fracture, a telephone follow-up and file review will be conducted after 6 weeks. Any changes in treatment during the 6 weeks following the initial presentation will be recorded.

    Time frame: Day 1 (On the day of enrollment in the study in the emergency department)

  6. Exact fracture pattern of the initial X-ray images as determined by blinded experts

    The exact fracture pattern of the X-ray images as determined by blinded experts.

    Time frame: Day 1 (On the day of enrollment in the study in the emergency department)

  7. Radiographic posterior fat pad signs on the initial X-ray images as determined by blinded experts

    Radiographic posterior fat pad signs on the initial X-ray images taken during the initial presentation at the emergency room, which are assessed by blinded experts.

    Time frame: Day 1 (On the day of enrollment in the study in the emergency department)

  8. Interrater reliability of ultrasound findings

    The sonographic images from the elbow joint sonography are subsequently re-evaluated by blinded physicians in order to examine interrater variability.

    Time frame: Day 1 (On the day of enrollment in the study in the emergency department)

  9. Only in cases where there is initially no radiographically confirmed fracture: pain after 6 weeks

    If no fracture is initially visible on the initial X-ray, a follow-up telephone call is made after 6 weeks. The child's pain is assessed using the PROMIS® Numeric Rating Scale v1.0 - Parent Proxy Pain Intensity 1a. This is a single-item scale for assessing average pain intensity from the parent's perspective (parent proxy), which has been validated for the 5 to 17 age group. The child's average pain intensity is recorded on a numerical scale from 0 ("no pain") to 10 ("the most severe pain imaginable"), taking into account the period of the last seven days.

    Time frame: Day 39-45 (42 days (+/- 3 days) after the day of enrollment in the study in the emergency department)

  10. Only in cases where there is initially no radiographically confirmed fracture: function of the upper extremity after 6 weeks

    If no fracture is initially visible on the initial X-ray, a follow-up telephone call is made after 6 weeks: The function of the child's upper extremity is assessed using the PROMIS® Parent Proxy Short Form v2.0 - Upper Extremity questionnaire. This is an official, validated short form derived from the PROMIS® item bank for upper extremity function from the parent's perspective (parent proxy). It assesses the limitations of children (aged 5-17 years) in relation to everyday activities that involve the upper extremities. The eight items are rated on a five-point Likert scale ranging from "No difficulty" to "Could not do." The final result is represented by the T-score-a standardized value with a mean of 50 and a standard deviation of 10.

    Time frame: Day 39-45 (42 days (+/- 3 days) after the day of enrollment in the study in the emergency department)

  11. Only in cases where there is initially no radiographically confirmed fracture: Medical follow-up appointments and results of possible further radiological imaging

    After six weeks, the patient file is reviewed for possible re-examination at the study center. In the event of a re-examination, the date, symptoms, and, if applicable, any X-ray imaging, fracture type, and treatment are documented. In addition, the parents are contacted by telephone after six weeks and asked about a possible appointment at an external clinic or doctor's office. If such a referral has taken place, the findings and any changes in treatment are recorded. If a bone fracture has been diagnosed for the first time in an external facility due to the same trauma, the X-ray images and findings are requested to be sent to the local study center so that they can be integrated into the patient file.

    Time frame: Day 39-45 (42 days (+/- 3 days) after the day of enrollment in the study in the emergency department)

Other outcomes

  1. Potential confounders of the primary outcome

    Potential confounders of the patients include age, sex assigned at birth, gender identity, pre-existing conditions, location of the accident (in daycare/school or outside of these settings), accident mechanism, swelling of the affected elbow, hematoma of the affected elbow, other fractures caused by the same trauma, and the time interval since the trauma. Potential confounders of the attending physician in the emergency room, who is performing the sonography include previous experience with ultrasound imaging of fractures, the physician's area of expertise, and level of training.

    Time frame: Day 1 (On the day of enrollment in the study in the emergency department)

07

Study locations

2 of 13 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All IPD collected throughout the trial.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: Individual participant data will be made available beginning 6 months following the publication of the primary manuscript in a peer-reviewed journal. To ensure long-term reproducibility and transparency, the data will be hosted in a permanent data repository [e.g., Zenodo] with no set expiration date.

Access criteria: De-identified individual participant data and supporting documents (Protocol, SAP, Analytic Code) will be made available to qualified researchers for legitimate scientific purposes. Access will be managed through a restricted-access data repository [e.g., Zenodo]. To obtain access, researchers must submit a formal request through the repository's 'Request Access' feature, including a brief research proposal and a statistical analysis plan. Requests will be reviewed by the study investigators to ensure scientific merit and ethical compliance. Upon approval, and following the signing of a Data Access Agreement to protect participant confidentiality, the data will be released directly through the repository platform.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2026 (actual). Primary completion is estimated for Nov 2026, 7 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 15, 2026
First posted
Feb 24, 2026
StartActual
Mar 2, 2026
Primary completionEst.
Nov 1, 2026
CompletionEst.
Jan 15, 2027
Last update
Apr 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07429344
Lead sponsor
Timo Munz
Collaborators
University Hospital Dresden, Helios Klinikum Berlin-Buch, Abteilung für Orthopädie und Unfallchirurgie BG Unfallklinik Duisburg, University Hospital Freiburg, Universitätsklinikum Hamburg-Eppendorf, Klinikum Kassel, Vivantes Hospital Berlin Neukölln, Klinikum Stuttgart, Klinikum Chemnitz gGmbH, University Hospital Lübeck, University Hospital Tuebingen
Responsible party
Timo Munz (Dr. med. Timo Munz, Principal Investigator, Charite University, Berlin, Germany) — Sponsor-investigator
First posted
Feb 24, 2026
Start date
Mar 2, 2026
Primary completion
Nov 1, 2026 (estimated)
Completion
Jan 15, 2027 (estimated)
Last update
Apr 8, 2026

Study contacts

Timo Munz, Dr. med.
Contact
timo.munz@charite.de
0049-30-450666875

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion